Alex Zhavoronkov is a scientist working in biotechnology, regenerative medicine and aging economics. He is founder of Insilico Medicine, the director of the Biogerontology Research Foundation, a UK-based think-tank for aging research, and the director of the International Aging Research Portfolio, an open-access repository of biomedical grants. He is also an adjunct professor at the Moscow Institute of Physics and Technology.
Zhavoronkov earned two bachelor's degrees at Queen's University in computer science and commerce. He has a master's in biotechnology from Johns Hopkins University and a PhD in physics and mathematics from Moscow State University.
He is the co-founder and CEO of Insilico Medicine, a deep learning company focused on drug discovery and biomarker development for aging and aging-associated diseases located at the Emerging Technology Centers of the Johns Hopkins University.
Since 2011, Dr. Zhavoronkov authored and co-authored over 108 scientific articles published in refereed journals with over 85 papers referenced in PubMed. Many of the highest-impact research papers focus on the applications of deep learning techniques to drug discovery, biomarker development, and aging research.
In November 2017 together with the collaborators from the BitFury Group he proposed the application of the deep learning techniques and blockchain technology for managing human life data, , , and presented the concept at the Singularity University Exponential Medicine conference in San Diego.
Dr. Zhavoronkov is the editor of Aging and associate editor of Frontiers in Genetics of Aging. He co-founded the "Annual Aging Research for Drug Discovery Forum" in Basel, Switzerland in 2014, previously called the International Symposium on Geroprotectors  as part of the EMBO/Basel Life.
- The Ageless Generation: How Advances in Biomedicine Will Transform the Global Economy, Macmillan, 2013
- Dating A.I.: A guide to falling in love with Artificial Intelligence, RE/Search, 2012
- MIPT MIPT News: Neural network learns to select potential anticancer drugs 02.09.2017
- Executive Profile of Alexander Zhavoronkov Bloomberg.com
- Artificial Intelligence: will it change the way drugs are discovered? Pharmaceutical Journal, The Journal of the Royal Pharmacological Society
- GenomeWeb: In Silico Medicine Opens US Office, Prepares to Launch Drug Discovery Software for Aging Research Market by Uduak Grace Thomas, March 28, 2014
- Baltimore Sun, Insilico Medicine raises $10 million, by Sarah Gantz, February 23, 2017
- Google Scholar by Publication Date Google Scholar by Publication Date
- PubMed Bibliography Pubmed
- Google Scholar by Citation Google Scholar by Citation
- Skolkovo Commentary: Skolkovo scientist says AI and blockchain could accelerate biomedical research
- Bitcoin Tech Can Let You Decide Who Buys Your Data, Says Medical Startup
- This Biotech Company Wants You to Give it Selfies and Blood Tests in Exchange for Cryptocurrency
- Alex Zhavoronkov presentation at the Exponential Medicine
- Singularity University Hub: AI to Scour a Universe of Molecules for Wonder Drugs
- Aging Editorial Board
- Frontiers in Genetics of Aging Editorial Board
- New Scientist report from the International Symposium on Geroprotectors in Basel
- 4th Annual Aging Research & Drug Discovery Forum in Basel, Switzerland
- Bloomberg Business week, Critic 07.22.2013 pp. 74
- CBS Radio with Dan Raviv in Washington, DC
- Book Tour Radio